The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Efficacy and Safety of Sildenafil Citrate for Treatment of Erectile Dysfunction in a Population With Associated Organic Risk Factors
Abstract
ABSTRACT: The objective of this study was to determine the efficacy and safety of sildenafil in patients with erectile dysfunction (ED) and associated organic risk factors in a multispecialty clinic. Patients (n = 521) were diagnosed with ED based on self‐assessment. Associated risk factors were managed by medication or lifestyle modifications, or both, before treatment with sildenafil for ED. Patients received a 50‐mg dose of sildenafil that could be adjusted to 100 mg or 25 mg based on tolerability and efficacy. Patients recorded the number of successful intercourse encounters for 6 to 8 weeks, and the number of adverse events. Overall, there was an 82% successful intercourse rate with sildenafil treatment. The predominant associated risk factors for ED were hypertension (39%), hypogonadism (37%), and multiple medications (34%). Common adverse events due to sildenafil treatment were mild to moderate in nature and resulted in <2% patient discontinuation. Clinicians should be particularly careful to evaluate patients presenting with ED because the condition can be accompanied by a wide spectrum of risk factors requiring monitoring and treatment. However, with adequate treatment and control of these risk factors, the use of sildenafil in a representative population of men with ED in a multispecialty clinic can achieve a higher efficacy rate than previous studies have indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Testosterone deficiency seems to predict a poor response to sildenafil10-12 or tadalafil13 and the addition of testosterone seemed helpful in five uncontrolled studies.12-14”
From Treatment Strategy for Non-Responders to PDE5 Inhibitors (2013) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
Guay, A. T. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3546 · Cited by 150
Self-citation
Research works printed but not linked: 25
- American Association of Clinical Endocrinologists., 1998, AACE clinical practice guidelines for the evaluation and treatment of male sexual dysfunction, Endocr Pract, 4, 220
- 10.1016/S0022-5347(01)66141-X · DOI
- Benet AE, 1994, Male erectile dysfunction assessment and treatment options, Compr Ther, 20, 669
- 10.1080/00325481.1983.11698466 · DOI
- Cheitlin MD, 1999, Use of sildenafil (Viagra) in patients with cardiovascular disease, Cardiology, 99, 168
- 10.1016/S0895-7061(97)90739-1 · DOI
- 10.1016/S0022-5347(01)65861-0 · DOI
- Greiner KA, 1996, Erectile dysfunction [see comments], Am Fam Physician, 54, 1675
- 10.4158/EP.4.1.23 · DOI
- 10.4158/EP.5.6.314 · DOI
- Jackson G., 1999, A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement, Int J Clin Pract, 53, 445, 10.1111/j.1742-1241.1999.tb11771.x · DOI
- 10.1097/00005392-199909010-00024 · DOI
- 10.1210/jcem-71-4-963 · DOI · Paper page
- 10.1056/NEJM200006153422407 · DOI · Paper page
- 10.1016/S0090-4295(98)00525-1 · DOI
- 10.1016/S0022-5347(05)67139-X · DOI
- Masters WH, 1988, Human Sexuality
- McClure RD., 1988, Endocrine evaluation and therapy of erectile dysfunction, Urol Clin North Am, 15, 53, 10.1016/S0094-0143(21)00869-7 · DOI
- 10.1016/S0022-5347(17)49454-7 · DOI
- 10.1001/jama.1993.03510010089036 · DOI · Paper page
- 10.1016/S0025-7125(16)30076-1 · DOI
- Padma‐Nathan H., 1998, Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double‐blind, placebo‐controlled study of 329 patients, Int J Clin Pract, 52, 375, 10.1111/j.1742-1241.1998.tb08886.x · DOI
- 10.1001/jama.281.5.421 · DOI
- 10.1016/S0090-4295(99)00310-6 · DOI
- Zonszein J., 1995, Diagnosis and management of endocrine disorders of erectile dysfunction, Urol Clin North Am, 22, 789, 10.1016/S0094-0143(21)00695-9 · DOI
Cited by
Shamloul, R., & Ghanem, H. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60520-0 · Cited by 1,091
Aversa, A., Isidori, A. M., Spera, G., Lenzi, A., & Fabbri, A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01764.x · Cited by 343
Porst, H., Padma-Nathan, H., Giuliano, F., Anglin, G., Varanese, L., & Rosen, R. (2003) · Urology · doi:10.1016/s0090-4295(03)00359-5 · Cited by 320
Traish, A. M., & Guay, A. T. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00245.x · Cited by 196
Self-citationKalinchenko, S. Y., Kozlov, G. I., Gontcharov, N. P., & Katsiya, G. V. (2003) · The Aging Male · doi:10.1080/tam.6.2.94.99 · Cited by 173
Yassin, A. A., Saad, F., & Traish, A. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00267.x · Cited by 96
Treatment Strategy for Non-Responders to PDE5 Inhibitors
Park, N. C., Kim, T. N., & Park, H. J. (2013) · The World Journal of Men's Health · doi:10.5534/wjmh.2013.31.1.31 · Cited by 41
Mulhall, J. P., Brock, G. B., Glina, S., Baygani, S., Donatucci, C. F., & Maggi, M. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.02.163 · Cited by 7
Metadata
- Authors
- GUAY, A. T., PEREZ, J. B., JACOBSON, J., & NEWTON, R. A.
- Venue
- Journal of Andrology
- Publisher
- Wiley
- Published
- 2001-09-10
- Volume
- 22
- Issue
- 5
- Pages
- 793-797
- ISSN
- 0196-3635
- 1939-4640
- Cited by
- 103
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
